HPV vaccination campaign starts in Churachandpur
Churachandpur: The Human Papillomavirus (HPV) vaccination campaign for 14-year-old girls was launched in Churachandpur district on Friday, following the nationwide rollout by Prime Minister Narendra Modi on Feb 28 in Ajmer, Rajasthan.
The initiative, introduced under the ministry of health and family welfare, aims to protect adolescent girls from cervical cancer, the second leading cancer among women in India. Health officials said nearly 99.7% of cervical cancer cases are linked to HPV.
Officials said the vaccine has been safely administered in 155 countries for more than 15 years and will be provided free of cost under the govt programme.
The campaign will run for three months in a single-age cohort mode before being integrated into the routine immunization programme.
Vaccinations will be conducted every Monday, Wednesday and Friday at the District Immunisation Centre (DIC), Behiang PHC, Singngat CHC, Sinzawl PHC, Thanlon PHC, Sagang PHC and Saikot PHC, according to health officials.
The HPV vaccine, which costs around Rs 4,000 per dose in the private sector, is expected to significantly reduce the burden of cervical cancer by ensuring equitable access for adolescent girls.
The initiative, introduced under the ministry of health and family welfare, aims to protect adolescent girls from cervical cancer, the second leading cancer among women in India. Health officials said nearly 99.7% of cervical cancer cases are linked to HPV.
Officials said the vaccine has been safely administered in 155 countries for more than 15 years and will be provided free of cost under the govt programme.
The campaign will run for three months in a single-age cohort mode before being integrated into the routine immunization programme.
Vaccinations will be conducted every Monday, Wednesday and Friday at the District Immunisation Centre (DIC), Behiang PHC, Singngat CHC, Sinzawl PHC, Thanlon PHC, Sagang PHC and Saikot PHC, according to health officials.
The HPV vaccine, which costs around Rs 4,000 per dose in the private sector, is expected to significantly reduce the burden of cervical cancer by ensuring equitable access for adolescent girls.
Next Story